Search research articles
Contact Us
Filters
Showing results (21-30 of 123) with videos related to
Page
of 13
Sort By:
Nucleic Acids Research
|
November 4, 1998
Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts
M Scherr, J J Rossi
The Journal of Antimicrobial Chemotherapy
|
August 1, 1996
Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?
S Akhtar, J J Rossi
Trends in Biotechnology
|
July 1, 1990
RNA enzymes (ribozymes) as antiviral therapeutic agents
J J Rossi, N Sarver
Gene Therapy
|
September 30, 2011
Current progress in the development of RNAi-based therapeutics for HIV-1
J Zhou, J J Rossi
Advances in Experimental Medicine and Biology
|
January 1, 1992
Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents
J J Rossi, N Sarver
Nucleic Acids Research
|
December 25, 1992
Small sequence insertions within the branch point region dictate alternative sites of lariat formation in a yeast intron
D Castanotto, J J Rossi
Antisense & Nucleic Acid Drug Development
|
September 13, 2000
Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts
L Cagnon, J J Rossi
Methods in Enzymology
|
October 5, 2001
Intracellular applications of ribozymes
A Michienzi, J J Rossi
Nucleic Acids Research
|
September 2, 1998
Cooperative interaction of branch signals in the actin intron of Saccharomyces cerevisiae
D Castanotto, J J Rossi
RNA (New York, N.Y.)
|
July 20, 1999
The first ATPase domain of the yeast 246-kDa protein is required for in vivo unwinding of the U4/U6 duplex
D H Kim, J J Rossi
Page
of 13
Search research articles
Search
Showing results (21-30 of 123) with videos related to
Sort By:
Page
of 13
Nucleic Acids Research
|
November 4, 1998
Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts
M Scherr, J J Rossi
The Journal of Antimicrobial Chemotherapy
|
August 1, 1996
Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?
S Akhtar, J J Rossi
Trends in Biotechnology
|
July 1, 1990
RNA enzymes (ribozymes) as antiviral therapeutic agents
J J Rossi, N Sarver
Gene Therapy
|
September 30, 2011
Current progress in the development of RNAi-based therapeutics for HIV-1
J Zhou, J J Rossi
Advances in Experimental Medicine and Biology
|
January 1, 1992
Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents
J J Rossi, N Sarver
Nucleic Acids Research
|
December 25, 1992
Small sequence insertions within the branch point region dictate alternative sites of lariat formation in a yeast intron
D Castanotto, J J Rossi
Antisense & Nucleic Acid Drug Development
|
September 13, 2000
Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts
L Cagnon, J J Rossi
Methods in Enzymology
|
October 5, 2001
Intracellular applications of ribozymes
A Michienzi, J J Rossi
Nucleic Acids Research
|
September 2, 1998
Cooperative interaction of branch signals in the actin intron of Saccharomyces cerevisiae
D Castanotto, J J Rossi
RNA (New York, N.Y.)
|
July 20, 1999
The first ATPase domain of the yeast 246-kDa protein is required for in vivo unwinding of the U4/U6 duplex
D H Kim, J J Rossi
Page
of 13